261 related articles for article (PubMed ID: 9724862)
1. Shortening duration of treatment of multibacillary leprosy.
Compostella L
Indian J Lepr; 1998; 70(2):221-3. PubMed ID: 9724862
[No Abstract] [Full Text] [Related]
2. Shortening duration of treatment of multibacillary leprosy. Action Programme for the Elimination of Leprosy, WHO.
Indian J Lepr; 1997; 69(3):267-70. PubMed ID: 9394176
[No Abstract] [Full Text] [Related]
3. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
Pattyn S; Grillone S
Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
[TBL] [Abstract][Full Text] [Related]
4. Relapses in multibacillary leprosy patients after multidrug therapy.
Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
[TBL] [Abstract][Full Text] [Related]
5. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
Ji B
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
[No Abstract] [Full Text] [Related]
6. Relapsing multibacillary leprosy--a new dimension to transmission in urban areas.
Ganapati R; Bulchand HO; Pai VV; Kingsley S; Revankar CR
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):114-5. PubMed ID: 11757168
[No Abstract] [Full Text] [Related]
7. Relapse following fixed duration treatment for multibacillary leprosy.
Wkly Epidemiol Rec; 1994 Oct; 69(41):301-2. PubMed ID: 7986699
[No Abstract] [Full Text] [Related]
8. Status of the multibacillary leprosy patients treated with combined regimens of 1 year duration, after a mean follow-up of more than 5 years.
Pattyn SR; Bourland J; Deverchin J; Ghys P; Grillone S; Groenen G; Janssens L; Kuykens P
Lepr Rev; 1991 Sep; 62(3):337-9. PubMed ID: 1795593
[No Abstract] [Full Text] [Related]
9. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the incidence of type 2 reactions in lepromatous leprosy with two regimens of treatment.
Manungo J; Thomas JE
Cent Afr J Med; 1982 Sep; 28(9):209-11. PubMed ID: 7151141
[No Abstract] [Full Text] [Related]
11. A comparative study between 12 and 24-dose therapeutic regimens for multibacillary leprosy patients.
Sales AM; Sabroza PC; da Costa Nery JA; Duppre NC; Sarno EN
Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):320-3. PubMed ID: 15485290
[TBL] [Abstract][Full Text] [Related]
12. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
13. Defaulting patterns in a provincial leprosy control programme in Northern Mozambique.
Griffiths S; Ready N
Lepr Rev; 2001 Jun; 72(2):199-205. PubMed ID: 11495451
[TBL] [Abstract][Full Text] [Related]
14. Elimination of leprosy from India--prospects & challenges.
Noordeen SK
Indian J Public Health; 2003; 47(4):183-7. PubMed ID: 15125560
[No Abstract] [Full Text] [Related]
15. A comparative trial of single-dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
Desikan KV
Indian J Lepr; 2001; 73(4):364-6; author reply 366-7. PubMed ID: 11898472
[No Abstract] [Full Text] [Related]
16. Duration of MDT for paucibacillary leprosy.
Ramu G
Indian J Lepr; 1992; 64(1):1-7. PubMed ID: 1290484
[No Abstract] [Full Text] [Related]
17. Characteristics and treatment outcomes of leprosy patients detected during a leprosy elimination campaign in Mozambique compared with routinely detected patients.
Phaff C; Van Den Broek J; MacArthur A; Ndeve A; Stuip Y
Lepr Rev; 2003 Sep; 74(3):229-39. PubMed ID: 14577468
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
19. A study on non-adherence to MDT among leprosy patients.
Rao PS
Indian J Lepr; 2008; 80(2):149-54. PubMed ID: 19425509
[TBL] [Abstract][Full Text] [Related]
20. Multidrug therapeutic challenges in leprosy.
Jain S; Sehgal VN
Int J Dermatol; 1997 Jul; 36(7):493-6. PubMed ID: 9268743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
